Literature DB >> 6321310

Is ethanol metabolism affected by oral administration of cimetidine and ranitidine at therapeutic doses?

G Dobrilla, G de Pretis, L Piazzi, F Chilovi, M Comberlato, M Valentini, A Pastorino, P Vallaperta.   

Abstract

The aim of this study was to compare the ethanol serum concentration curve, the area under the curve and subjective response after acute ingestion of ethanol (red wine, 13 degrees proof, at a dose of 0.8 g/kg of ideal weight in 6 healthy volunteers with a mean habitual alcohol intake of 20 g/day. All the subjects underwent the test a total of three times, after pre-treatment with cimetidine (400 mg X 2/day/7 days) and ranitidine (150 mg X 2/day/7 days), respectively, and after receiving no pre-treatment. The wine was taken orally within the space of 15 min, four hours after taking a standard-weight ham sandwich. Blood samples were drawn at the following times: 0, 30, 60, 90, 120, 180, 240 and 360 minutes. The plasma ethanol curve of the subjects pre-treated with cimetidine lies above that of the subjects pre-treated with ranitidine, and largely coincides with the curve obtained in those who received no pre-treatment, with the exception of the initial hour-and-a-half, when the later show a slightly higher mean plasma concentration. The differences between the three treatment groups are merely arithmetical, but not statistical, with respect to peak plasma ethanol concentrations, time elapsing before peaking, and areas under the curves. These results are at variance with some published data suggesting a significant interaction of cimetidine with the metabolism of alcohol by way of interference either with the hepatic oxidative metabolizing enzymes, or with the activity of alcohol dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321310

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  12 in total

1.  Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers.

Authors:  K A Jönsson; A W Jones; H Boström; T Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Effects of H2-receptor antagonists on ethanol metabolism in Japanese volunteers.

Authors:  E Tanaka; K Nakamura
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Histamine H2 receptor antagonists and blood alcohol levels.

Authors:  G Holtmann; M V Singer
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

Review 5.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 6.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

7.  Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolism.

Authors:  A S Brown; J R Fiaterone; C P Day; M K Bennett; P J Kelly; O F James
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 9.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

Review 10.  H2-antagonists and alcohol. Do they interact?

Authors:  R Gugler
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.